FDA+ channel feed – Endpoints News

FDA+ channel feed

Another big biopharma merger runs into another snag at the FTC. What now?

6 years ago

OND reorganization moves forward

6 years ago

Republicans rebuke Pelosi drug pricing bill

6 years ago

FDA endorses Bavarian Nordic's monkeypox vaccine, marking world's first approval

6 years ago

Novartis accuses 2 AveXis founders of altering data, stonewalling probe — but ex-CSO blasts back

6 years ago

Embattled AMAG braces for October FDA Makena adcom, but it need not worry — analyst

6 years ago

GW Pharma's cannabis-derived epilepsy medicine makes the cut in the European Union

6 years ago

FDA puts the brakes on a rare disease biotech’s PhIII as regulators wait for an update — shares crumble

6 years ago

Intrexon unit pushes back against claims its GM mosquitoes are making disease-friendly mutants

6 years ago

Emmaus rescinds EU marketing application, following negative review

6 years ago

FDA lays out tech modernization action plan

6 years ago

Population pharmacokinetics: Drugmakers seek clarity and additions to revised FDA guidance

6 years ago

FDA collaborates with Health Canada, Australia to approve new cancer drugs

6 years ago

Last rites for Sienna, as struggling biotech files for Chapter 11

6 years ago

FDA explains plans for new pharmaceutical quality assessment system

6 years ago

Seattle Genetics/Astellas win priority US review for armed antibody aimed at bladder cancer

6 years ago

EMA, FDA begin reviewing heartburn medicines for carcinogen

6 years ago

It's not perfect, but it's a good start: FDA panelists largely endorse Aimmune's peanut allergy therapy

6 years ago

Vertex deal for Scotland — no deal for England

6 years ago

FDA developing guidance on real-world data quality issues, officials say

6 years ago

Novartis makes new data integrity commitment

6 years ago

Boehringer Ingelheim's Ofev wins FDA approval for use in scleroderma patients

6 years ago

Stephen Hahn, 'clear frontrunner' for FDA commish job, has met with Trump — reports

6 years ago

How much has the cancer R&D frenzy translated into drug approvals? A lot

6 years ago

First page Previous page 139 140 141142143 144 145 Next page Last page